Patients with chronic rhinosinusitis with nasal polyps and uncontrolled asthma experienced greater improvements in lung ...

For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body -- a job commonly given to adeno-associated viruses (AAV). To improve the AAV ...

ENA Respiratory has raised US$22.4m (AU$34m) in Series B financing to support the phase 2 clinical development of its nasal ...

SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

The next fight against COVID and the flu may be as simple as the spritz of a nasal spray containing non-drug ingredients already used in other similar products. Researchers at Harvard and Brigham and ...

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense enhancers to minimize the impact of symptomatic viral respiratory infections, announces today that it has ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Researchers at Oxford announced today that a nasal spray version of ...

A team of researchers at the Näär Lab at UC Berkeley have developed a new inhalable drug that blocks the viral replication of SARS-CoV-2 in lung cells. The drug is a type of antisense oligonucleotide, ...

Common side effects of the flu vaccine include soreness, muscle aches, headache, mild fever, and nausea. These are normal and not cause for concern.